InMode's Q3 Financial Overview
InMode Ltd. (NASDAQ: INMD) recently shared its consolidated financial results for the third quarter. The company continues to be a key provider of innovative medical technologies, and their performance highlights reveal critical insights into their operations.
Financial Highlights
During the third quarter, InMode reported GAAP revenues of $93.2 million. This represents a decline compared to the $130.2 million reported for the same period last year. The previous year's figures included $31.9 million from pre-order sales, which impacted the year-over-year comparison.
Revenue from consumables and service rose by 26% year over year, amounting to $19.9 million for Q3 2025. This growth underscores InMode's strong market position and demand for its consumable products.
The company achieved a GAAP operating income of $20.9 million, while its non-GAAP operating income stood at $23.6 million. At the same time, InMode's total cash position reached an impressive $532.3 million, comprising cash, marketable securities, and short-term deposits.
Detailed Financial Performance
The breakdown of InMode's financial performance sheds light on the company’s trajectory and overall health. Gross margins were recorded at 78% for Q3 2025, compared to 82% in Q3 2024, indicating a need for continued efficiency improvements.
Net income for the third quarter was $21.9 million, delivering earnings of $0.34 per diluted share. For comparison, in Q3 2024, InMode reported a net income of $51.0 million, or $0.65 per diluted share.
Non-GAAP results for Q3 2025 showed a net income of $24.5 million and earnings of $0.38 per diluted share, while the previous year’s figures were $55.0 million and $0.70 per diluted share respectively.
Management Commentary
CEO Moshe Mizrahy expressed optimism regarding the company’s strategic direction amidst a cautious consumer sentiment and global uncertainties. The leadership team is focused on executing plans that include investment in key growth areas to sustain InMode’s long-term growth.
Furthermore, the appointment of Michael Dennison as the new President of North America is expected to enhance regional strategy and customer engagement, as he brings extensive experience since joining InMode in 2018.
The CFO of InMode, Yair Malca, mentioned that the gross margins aligned with their expectations, largely due to proactive tariff planning, indicating a strategic approach to managing costs.
Future Outlook for 2025
Looking ahead, management has outlined an outlook for the fiscal year ending December 31, 2025. They anticipate revenues will remain steady within the guidance range of $365 million to $375 million. Non-GAAP gross margins are also expected to maintain between 78% and 80%.
Additionally, non-GAAP income from operations is expected to fall between $93 million and $98 million, reiterating the firm’s financial resilience despite market challenges. Similarly, non-GAAP earnings per diluted share are projected between $1.55 and $1.59, reflecting the company’s commitment to delivering shareholder value.
Conclusion
Despite encountering headwinds, InMode Ltd. is navigating its financial landscape with strategic investments and leadership in the medical technology space. As they continue to focus on their operational efficiency and market position, stakeholders remain hopeful for their long-term success.
Frequently Asked Questions
What were InMode's revenues for Q3 2025?
InMode reported Q3 2025 revenues of $93.2 million.
How did the revenues compare to the previous year?
Revenues in Q3 2024 were $130.2 million, which included substantial pre-order sales.
What is InMode's projected revenue range for 2025?
Management expects revenues to be between $365 million and $375 million for 2025.
What is the significance of the 78% gross margin?
The 78% gross margin indicates efficient operations, although it is lower than the previous year's margin of 82%.
Who is the new President of North America?
Michael Dennison has been appointed as the new President of North America.
